It was also found by other studies that biomarkers for the prognosis of colon cancer, including microsatellite instability-high (23), CpG island methylator phenotype-high (24), RAS (25), phosphoinositide 3-kinase pathway (26), and BRAF mutations (24). This evidence concerns the gene BRAF and colonic neoplasm.